Matthew Solomon: Why Secondary Analyses of Clinical Trials Matter for Better Care
Matthew Solomon, Chief Scientific Officer at Sutter Health, shared a post on LinkedIn about a recent article by Harlan Krumholz and Harold Hines, published in JACC:
”Going through my stack of JACCs and this one really caught my eye
Kudos to the editorial team at the Journal of the American College of Cardiology for dedicating an entire issue to secondary analyses of clinical trials. It’s easy to focus only on primary endpoints, but there’s so much valuable learning in what comes next.
While some secondary results are hypothesis-generating, many offer critical clinical insights that help us understand nuances in treatment effects, patient subgroups, long-term outcomes, and underlying biology. Shining a spotlight on this work helps us translate trial evidence into better care.
Big thanks to the editors for the emphasis on this often under-appreciated yet essential part of clinical research.
What secondary analyses can do:
- Reveal effects in subpopulations that weren’t the focus of the primary endpoint
- Explore mechanistic insights or biological signals not captured by the primary outcome
- Extend follow-up to look at longer-term outcomes
- Refine endpoints or composite outcomes for future trials
- Test consistency of effects across methods or clinical contexts
These analyses help close gaps between trial results and real-world practice – and that’s why they matter.”
Title: When the Trial Is Over: What Secondary Analyses Still Teach Us
Authors: Harlan Krumholz, Harold Hines
Read the Full Article on Journal of the American College of Cardiology
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 09:10Shall I Bleed Less with Age? Just 2 Weeks Until the Webinar – EHC
-
Apr 15, 2026, 08:51Moustafa Abdou: Sutimlimab is Transforming Outcomes in Cold Agglutinin Disease
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS